ResearcherJohns Hopkins UniversityNo recent work listed

Helen Catherine Wilbur

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5330-5084; OpenAlex author ID A5039085347. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2023: 1 paper

Papers 1

Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-23-0230 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dung Thi Le · 1 shared paper, 2023 · strength 0.17
- Paper Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. DOI 10.1158/2767-9764.crc-23-0230 ↗
Hao Wang · 1 shared paper, 2023 · strength 0.17
- Paper Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. DOI 10.1158/2767-9764.crc-23-0230 ↗
Ana De Jesus‐Acosta · 1 shared paper, 2023 · strength 0.17
- Paper Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. DOI 10.1158/2767-9764.crc-23-0230 ↗
Nilofer Saba Azad · 1 shared paper, 2023 · strength 0.17
- Paper Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. DOI 10.1158/2767-9764.crc-23-0230 ↗
Katherine M. Bever · 1 shared paper, 2023 · strength 0.17
- Paper Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. DOI 10.1158/2767-9764.crc-23-0230 ↗
Luis Alberto Diaz · 1 shared paper, 2023 · strength 0.17
- Paper Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. DOI 10.1158/2767-9764.crc-23-0230 ↗
Daniel A. Laheru · 1 shared paper, 2023 · strength 0.17
- Paper Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. DOI 10.1158/2767-9764.crc-23-0230 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.